ITRM vs MKC · rev $390.0K vs P/E 8.4, $13.56B cap
Iterum Therapeutics PLC (ITRM) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
MKC does not have a complete income-statement cache yet.
ITRM currently screens at market cap $38.6M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the ITRM and MKC stock pages for the full models.
Not investment advice.